Trade ERNA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Ernexa Therapeutics Inc. (ERNA) is trading at US$4.08, down 4.45% today as of Sep 15, 16:00 EDT. The company has a market capitalisation of US$5.67M. Over the past 52 weeks, ERNA has traded between US$0.13 and US$15.88. On Syfe you can trade ERNA with $0 commission and add it to your watchlist.
| Previous close | US$4.27 |
|---|---|
| Market cap | US$5.67M |
| 52-week range | US$0.13 – US$15.88 |
| Volume | 522.67K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Ernexa Therapeutics Inc.
Ernexa Therapeutics, Inc. engages in the research and development of cellular therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. Its pipeline includes ERNA-101 (Ovarian Cancer) and ERNA-201 (Rheumatoid Arthritis). The company was founded in 1984 and is headquartered in Cambridge, MA.
Year: 2021
Ernexa Therapeutics Says Preclinical Data Shows Anti-Tumor Activity of ERNA-101 Combination
Jul 15, 1:01 PM · MT Newswires
Ernexa Therapeutics Says Investigational New Drug Submission for ERNA-101 on Track for Q3
Jun 17, 1:19 PM · MT Newswires
Ernexa Therapeutics Inc. (ERNA) stock is trading at US$4.08, -4.45% from the previous close of US$4.27.
The market cap for Ernexa Therapeutics Inc. (ERNA) stock is approximately US$5.67M.
The 52-week high for Ernexa Therapeutics Inc. (ERNA) stock is US$15.88.
The 52-week low for Ernexa Therapeutics Inc. (ERNA) stock is US$0.13.
Ernexa Therapeutics Inc. (ERNA) does not currently pay a dividend.
Stay on top of ERNA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
